NCT00020930View on ClinicalTrials.gov

Cetuximab in Treating Patients With Stage IV Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2001

Primary Completion Date

August 31, 2002

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

cetuximab

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00020930 - Cetuximab in Treating Patients With Stage IV Colorectal Cancer | Biotech Hunter | Biotech Hunter